BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gómez-Hurtado I, Such J, Sanz Y, Francés R. Gut microbiota-related complications in cirrhosis. World J Gastroenterol 2014; 20(42): 15624-15631 [PMID: 25400446 DOI: 10.3748/wjg.v20.i42.15624]
URL: https://www.wjgnet.com/1007-9327/full/v20/i42/15624.htm
Number Citing Articles
1
Vera Odintsova, Natalia Klimenko, Alexander Tyakht, Olesya Volokh, Vladimir Popov, Dmitry Alexeev, Yulia Berezhnaya. Yogurt fortified with vitamins and probiotics impacts the frequency of upper respiratory tract infections but not gut microbiome: A multicenter double-blind placebo controlled randomized studyJournal of Functional Foods 2021; 83: 104572 doi: 10.1016/j.jff.2021.104572
2
Michał Grąt, Karolina M. Wronka, Zbigniew Lewandowski, Karolina Grąt, Maciej Krasnodębski, Jan Stypułkowski, Wacław Hołówko, Łukasz Masior, Irena Kosińska, Michał Wasilewicz, Joanna Raszeja-Wyszomirska, Sławomir Rejowski, Emil Bik, Waldemar Patkowski, Marek Krawczyk. Effects of continuous use of probiotics before liver transplantation: A randomized, double-blind, placebo-controlled trialClinical Nutrition 2017; 36(6): 1530 doi: 10.1016/j.clnu.2017.04.021
3
Valeria Maccauro, Carlo Airola, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani, Maurizio Pompili. Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial PeritonitisLife 2023; 13(4): 991 doi: 10.3390/life13040991
4
Petrus R. de Jong, José M. González-Navajas, Nicolaas J. G. Jansen. The digestive tract as the origin of systemic inflammationCritical Care 2016; 20(1) doi: 10.1186/s13054-016-1458-3
5
Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiotaWorld Journal of Gastroenterology 2023; 29(27): 4236-4251 doi: 10.3748/wjg.v29.i27.4236
6
Toru Shizuma. Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature reviewWorld Journal of Hepatology 2018; 10(2): 254-266 doi: 10.4254/wjh.v10.i2.254
7
Cristina Maria Marginean, Denisa  Pirscoveanu, Mihaela Popescu, Corina Maria Vasile, Anca Oana Docea, Radu Mitruț, Iulia Cristina Mărginean, George Alexandru Iacob, Dan Mihai Firu, Paul Mitruț. Challenges in Diagnosis and Therapeutic Approach of Acute on Chronic Liver Failure—A Review of Current EvidenceBiomedicines 2023; 11(7): 1840 doi: 10.3390/biomedicines11071840
8
Florence Wong. Zakim and Boyer's Hepatology2018; : 262 doi: 10.1016/B978-0-323-37591-7.00017-3
9
Qin Ning, Tao Chen, Guiqiang Wang, Dong Xu, Yanyan Yu, Qing Mao, Taisheng Li, Lanjuan Li, Jun Li, Xiaoju Lu, Jiabin Li, Zhiwei Li, Wenhong Zhang, Yonghong Xiao, Qinghua Meng, Yuqiang Mi, Jia Shang, Yunsong Yu, Yingren Zhao, Caiyan Zhao, Hong Zhao, Jianrong Huang, Jie Peng, Hong Tang, Xiaoping Tang, Jinhua Hu, Bijie Hu, Wei Guo, Bo Zheng, Baiyi Chen, Yuexin Zhang, Jia Wei, Jifang Sheng, Zhi Chen, Minggui Wang, Qing Xie, Yuming Wang, Fu-Sheng Wang, Jinlin Hou, Zhongping Duan, Lai Wei, Jidong Jia. Expert Consensus on Diagnosis and Treatment of End-Stage Liver Disease Complicated with InfectionsInfectious Diseases & Immunity 2022; 2(3): 168 doi: 10.1097/ID9.0000000000000055
10
Xuemei Tao, Ning Wang, Wenxin Qin. Gut Microbiota and Hepatocellular CarcinomaGastrointestinal Tumors 2015; 2(1): 33 doi: 10.1159/000380895
11
Mattia Paratore, Francesco Santopaolo, Giovanni Cammarota, Maurizio Pompili, Antonio Gasbarrini, Francesca Romana Ponziani. Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future PerspectivesJournal of Clinical Medicine 2021; 10(12): 2605 doi: 10.3390/jcm10122605
12
Xin Feng, Xiaoqing Li, Xin Zhang, Weiqing Chen, Yin Tian, Qingqing Yang, Yingying Yang, Hui Pan, Zheng Jiang, Stefania Cantore. Hepatic Encephalopathy in Cirrhotic Patients and Risk of Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-AnalysisBioMed Research International 2022; 2022: 1 doi: 10.1155/2022/2469513
13
Irina Efremova, Roman Maslennikov, Elena Poluektova, Maria Zharkova, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Elena Shirokova, Evgenii Kozlov, Anna Levshina, Vladimir Ivashkin. Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of CirrhosisMicroorganisms 2023; 11(9): 2202 doi: 10.3390/microorganisms11092202
14
Hiroshi Fukui. Gut Microbiota and Host Reaction in Liver DiseasesMicroorganisms 2015; 3(4): 759 doi: 10.3390/microorganisms3040759
15
Tawfik Khoury, Keren Tzukert, Roy Abel, Ayman Abu Rmeileh, Ronen Levi, Yaron Ilan. The gut‐kidney axis in chronic renal failure: A new potential target for therapyHemodialysis International 2017; 21(3): 323 doi: 10.1111/hdi.12486
16
Hiroshi Fukui. Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies UpdateGut and Liver 2021; 15(5): 666 doi: 10.5009/gnl20032
17
Tanya Ralli, Yub Raj Neupane, Zoya Saifi, Kanchan Kohli. Gut Microbiota as an Emerging Therapeutic Avenue for the Treatment of Nonalcoholic Fatty Liver DiseaseCurrent Pharmaceutical Design 2021; 27(46): 4677 doi: 10.2174/1389201022666210625141526
18
Tanya Ralli, Zoya Saifi, Neha Tyagi, Arya Vidyadhari, Vidhu Aeri, Kanchan Kohli. Deciphering the role of gut metabolites in non-alcoholic fatty liver diseaseCritical Reviews in Microbiology 2023; 49(6): 815 doi: 10.1080/1040841X.2022.2142091
19
Takeshi Kitai, W.H. Wilson Tang. Gut microbiota in cardiovascular disease and heart failureClinical Science 2018; 132(1): 85 doi: 10.1042/CS20171090
20
Adrian Boicean, Victoria Birlutiu, Cristian Ichim, Olga Brusnic, Danusia Maria Onișor. Fecal Microbiota Transplantation in Liver CirrhosisBiomedicines 2023; 11(11): 2930 doi: 10.3390/biomedicines11112930
21
Gursimran Kochhar, Tavankit Singh, Henry Dust, Rocio Lopez, Arthur J. McCullough, Xiuli Liu, John Fung, Bo Shen. Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver TransplantationInflammatory Bowel Diseases 2016; 22(7): 1670 doi: 10.1097/MIB.0000000000000830
22
Elina Manzhalii, Valentyna Moyseyenko, Vitalii Kondratiuk, Nataliia Molochek, Tetyana Falalyeyeva, Nazarii Kobyliak. Effect of a specific <i>Escherichia coli Nissle 1917</i> strain on minimal/mild hepatic encephalopathy treatmentWorld Journal of Hepatology 2022; 14(3): 634-646 doi: 10.4254/wjh.v14.i3.634
23
Nadir Abbas, Neil Rajoriya, Ahmed M Elsharkawy, Abhishek Chauhan. Acute-on-chronic liver failure (ACLF) in 2022: have novel treatment paradigms already arrived?Expert Review of Gastroenterology & Hepatology 2022; 16(7): 639 doi: 10.1080/17474124.2022.2097070
24
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Elena Shirokova. Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?World Journal of Clinical Cases 2021; 9(31): 9320-9332 doi: 10.12998/wjcc.v9.i31.9320
25
Rodney Dietert, Janice Dietert. The Microbiome and Sustainable HealthcareHealthcare 2015; 3(1): 100 doi: 10.3390/healthcare3010100
26
Hiroshi Fukui, Reiner Wiest. Changes of Intestinal Functions in Liver CirrhosisInflammatory Intestinal Diseases 2016; 1(1): 24 doi: 10.1159/000444436
27
Tim Hendrikx, Bernd Schnabl. Antimicrobial proteins: intestinal guards to protect against liver diseaseJournal of Gastroenterology 2019; 54(3): 209 doi: 10.1007/s00535-018-1521-8
28
Ting‐Chin David Shen, Nikolaos Pyrsopoulos, Vinod K. Rustgi. Microbiota and the liverLiver Transplantation 2018; 24(4): 539 doi: 10.1002/lt.25008
29
Damian Piotrowski, Anna Boroń-Kaczmarska. Bacterial infections and hepatic encephalopathy in liver cirrhosis–prophylaxis and treatmentAdvances in Medical Sciences 2017; 62(2): 345 doi: 10.1016/j.advms.2016.11.009
30
Radmila V Karpova, Ksenia S Russkova, Yuliya N Lavrentieva. <p>Increases in Autoantibody Level Associated with Degenerative Changes in the Intestinal Mucosa in Liver Cirrhosis</p>Clinical and Experimental Gastroenterology 2020; : 315 doi: 10.2147/CEG.S263176
31
Francesca Fianchi, Antonio Liguori, Antonio Gasbarrini, Antonio Grieco, Luca Miele. Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized TherapyInternational Journal of Molecular Sciences 2021; 22(12): 6485 doi: 10.3390/ijms22126485
32
Mamatha Bhat, Bianca M Arendt, Venkat Bhat, Eberhard L Renner, Atul Humar, Johane P Allard. Implication of the intestinal microbiome in complications of cirrhosisWorld Journal of Hepatology 2016; 8(27): 1128-1136 doi: 10.4254/wjh.v8.i27.1128
33
Mikio Kajihara, Shigeo Koido, Tomoya Kanai, Zensho Ito, Yoshihiro Matsumoto, Kazuki Takakura, Masayuki Saruta, Kumiko Kato, Toshitaka Odamaki, Jin-zhong Xiao, Nobuhiro Sato, Toshifumi Ohkusa. Characterisation of blood microbiota in patients with liver cirrhosisEuropean Journal of Gastroenterology & Hepatology 2019; 31(12): 1577 doi: 10.1097/MEG.0000000000001494
34
Xueying Wang, Min Ding, Weiwei Wang, Xiaojie Zheng, Cyriac Abby Philips, Nahum Méndez-Sánchez, Hongxu Jin, Xingshun Qi. Association Between Bowel Wall Thickening and Long-Term Outcomes in Decompensated Liver CirrhosisAdvances in Therapy 2024; 41(6): 2217 doi: 10.1007/s12325-023-02690-z
35
Rohan Dalal, Richard G McGee, Stephen M Riordan, Angela C Webster. Probiotics for people with hepatic encephalopathyCochrane Database of Systematic Reviews 2017; 2021(1) doi: 10.1002/14651858.CD008716.pub3
36
Matthew R. Panasevich, E. M. Morris, S. V. Chintapalli, U. D. Wankhade, K. Shankar, S. L. Britton, L. G. Koch, J. P. Thyfault, R. S. Rector. Gut microbiota are linked to increased susceptibility to hepatic steatosis in low-aerobic-capacity rats fed an acute high-fat dietAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2016; 311(1): G166 doi: 10.1152/ajpgi.00065.2016
37
Ciara E. Keogh, Danielle H.J. Kim, Matteo M. Pusceddu, Trina A. Knotts, Gonzalo Rabasa, Jessica A. Sladek, Michael T. Hsieh, Mackenzie Honeycutt, Ingrid Brust-Mascher, Mariana Barboza, Mélanie G. Gareau. Myelin as a regulator of development of the microbiota-gut-brain axisBrain, Behavior, and Immunity 2021; 91: 437 doi: 10.1016/j.bbi.2020.11.001
38
Mohd Talha Noor, Piyush Manoria. Immune Dysfunction in CirrhosisJournal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2016.00056
39
Roman Maslennikov, Irina Efremova, Vladimir Ivashkin, Maria Zharkova, Elena Poluektova, Elena Shirokova, Konstantin Ivashkin. Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trialWorld Journal of Hepatology 2022; 14(8): 1667-1677 doi: 10.4254/wjh.v14.i8.1667
40
Jinjian Huang, Jianan Ren, Luise Brakert, Jiao Jiao, Qinjie Liu, Gefei Wang, Xiuwen Wu, Steven W.M. Olde Damink. A New Scoring System to Predict Blood Stream Infections in Patients with Complicated Intra-Abdominal Infections: Experience from a Tertiary Referral Hospital in ChinaSurgical Infections 2018; 19(4): 459 doi: 10.1089/sur.2017.243